Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies;Pathologisch-anatomische aufarbeitung und befundung von lymphknoten bei gynäkologischen malignomen

Pathologe

Volumn 26, Issue 4, 2005, Pages 266-272

  Horn, L C ^a   Einenkel, J ^b   Hockel M ^b   Kolbl H ^c   Kommoss, F ^d   Lax, S F ^e   Riethdorf, L ^f   Schnurch H G ^g   Schmidt, D ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Institut fur Pathologie Mannheim   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f Institut fur Pathologie   (Germany)

^g Lukas Krankenhaus   (Germany)

Author keywords

Gynaecologic malignancies; Histology; Metastasis; Sentinel lymph nodes; Staging

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; ENDOMETRIUM CANCER; FEMALE GENITAL TRACT TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; ONCOLOGY; OVARY CANCER; QUALITY CONTROL; SENTINEL LYMPH NODE BIOPSY; SOLID TUMOR; TUMOR CELL; UTERINE CERVIX CANCER; UTERINE TUBE CARCINOMA; VAGINA CANCER; VULVA CANCER;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 21844443860     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-005-0764-3     Document Type: Article

References (62)

1. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, Steiniche T (2004) Sentinel lymph nodes in malignant melanoma. Extended histopathologic evaluation improves diagnostic precision. Cancer 100:1683-1691
2. Altgassen C, Gottschild D, Dürst M, Schneider A, Studiengruppe der AGO-Studie Uterus III (2002) Detektion des Sentinellymphknotens bei Patientinnen mit Zervixkarzinom. Prospektive klinische Multizenterstudie zur Detektion des Sentinellymphknotens bei Patientinnen zur Operation eines Zervixkarzinoms - AGO-Studie Uterus III. Geburtshilfe Frauenheilk 62:358-362
3. Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) (2001) Kurzgefaßte interdsiziplinäre AGO-Leitlinien für die Diagnostik und Therapie des Endometriumkarzinoms. Zentralbl Gynakol 124:58-62
4. Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) (2001) Kurzgefaßte interdsiziplinäre AGO-Leitlinien für die Diagnostik und Therapie des Zervixkarzinoms. Zentralbl Gynakol 123:292-298
5. Baltzer J (1991) Management des Zervixkarzinoms - postoperative Strahlenbehandlung nach Wertheim-Operation. Ja oder nein? Zentralbl Gynakol 113:661-665
6. Barranger E, Cortez A, Marpeau O et al. (2004) Histopathologic validation of the sentinel node concept in cervical cancer. Ann Oncol 15:870-874
7. Beckmann MW und Informastionszentrum für Standards in der Onkologie (ISTO) in der Deutschen Krebsgesellschaft (2004) Interdisziplinäre S2-Leitlinie für die Diagnostik und Therapie des Zervixkarzinoms. Zuckschwerdt, München Wien New York
8. Burchill SA, Selby PJ (2000) Molecular detection of low level disease in patients wtih cancer. J Pathol 190:6-14
9. Cady B (2000) Sentinel lymph node procedure in squamous cell carcinoma of the vulva. J Clin Oncol 18:2795-2797
10. Cote RJ, Peterson HF, Chaiwun B (1999) Role of immunohistochemical detection of lymph-node metastases in the management of breast cancer. Lancet 354:896-900
11. Dam PA van, Hauspy J, Vanderheyden T et al. (2003) Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 13:182-186
12. Dam PA van, Sonnemans H, van Dam PJ et al. (2004) Sentinel node detection in patients with vaginal carcinoma. Gynecol Oncol 92:89-92
13. Di Re E, Grosso G, Raspagliesi F, Baiocchi G (1996) Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol 62:199-202
14. Fanfani F, Ludovisi M, Zannoni GF et al. (2004) Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments. Gynecol Oncol 94:779-784
15. Fisher ER, Palekar A, Rockette H et al. (1978) Pathologic findings from the National Surgical Adjuvant Breast Cancer Project (protocol no. 4). Cancer 42:2032-2038
16. Fishman A, Klein A, Zemer R et al. (2000) Detection of mircometastases by cytokeratin 20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gyneol Oncol 77:399-404
17. Fitzgibbons PL, LiVolsi VA (2000) Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy. Surgical Pathology Committee of the College of American Pathologists, and the Association of Directors of Anatomic and Surgical Pathology. Am J Surg Pathol 24:1549-1551
18. Fitzgibbons PL, Page DL, Weaver D (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966-978
19. Girardi F, Pickel H, Winter R (1993) Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer. Gynecol Oncol 50:330-333
20. Goldhirsch A, Wood WC, Gelber RD et al. (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:1-9
21. Gospodarowicz MK, Miller D, Groome PA et al. for the UICC TNM Project (2004) The process for continous improvement of the TNM classification. Cancer 100:1-5
22. Hansen NM, Grube BJ, Te W (2001) Clinical significance of axillary micrometastases in breast cancer: how small is too small? American Society of Clinical Oncology, ASCO-Abstract Book, Abstract No. 91
23. Hermanek P, Hutter RVP, Sobin LH, Wittekind C (1999) Classification of isolated tumor cells and micrometastases. Cancer 86:2668-2673
24. Horn LC, Schmidt D (2002) Histopathologische Basisinformation und morphologische Prognosefaktoren beim Endometriumkarzinom. Zentralbl Gynakol 124:36-44
25. Horn LC, Fischer U, Bilek K (2001) Pathologisch-anatomische Aufarbeitung und morphologische Basisinformation für das Management von Dysplasien und Karzinomen der Cervix uteri. Zentralbl Gynakol 123:255-265
26. Kjörstad KE, Kolbensvedt A, Stricker T (1984) Value of a complete lymphadenectomy in the radical treatment of cancer on the cervix. Cancer 54:2215-2219
27. Kühn T, Kreienberg R (2004) Wächterlymphknoten-Biopsie beim Mammakarzinom. Deutsche Gesellschaft für Senologie definiert Qualitätsstandards. Dtsch Med Wochenschr 129:387-390
28. 18FDG- Positronen-Emissions-Tomographie beim Zervixkarzinom: Erste Ergebnisse. Zentralbl Gynakol 123:229-235
29. Kuhn W, DuBois A, Pfisterer J (2001) Operative Therapie des fortgeschrittenen Ovarialkarzinoms. Gynäkologe 43:1050-1057
30. Lawrence WD (2001) ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virch Arch 439:601-603
31. Lax SF (2002) Molekulare Pathogenese des Endometriumkarzinoms auf der Basis eines dualistischen Modells. Zentralbl Gynakol 124:10-16
32. Lee E, Chae Y, Kim I et al. (2002) Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer 94:2867-2873
33. Lelievre L, Camatte S, Le Ferere-Belda MA et al. (2004) Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cyncer 14:271-278
34. Lentz SE, Muderspach LI, Felix JC et al. (2004) Identification of mircometastases in histologically negative nodes of early-stage cervical cancer patients. Obstet Gynecol 103:1204-1210
35. Levavi H, Sabah G, Hardoff R et al. (2003) Failure of sentinel node identification following neo-adjuvant chemo-radiotherapy for locally advanced squamous cell carcinoma of the vulva. Eur J Gynaecol Oncol 24:433-434
36. Marchiolè P, Buénerd A, Scoazec JY et al. (2004) Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100:2154-2159
37. Martínez-Palones JM, Gil-Moreno A, Pérez-Benavente MA et al. (2004) Interoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfane blue dye injection. Gynecol Oncol 92:845-850
38. Michel G, Morice P, Castaigne D et al. (1998) Lymphatic spread in stage IB an II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 91:360-363
39. Moore RG, Granai CO, Gajewski W et al. (2003) Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 91:378-382
40. Morice P, Castaigne D, Pautier P et al. (1999) Interest of para-aortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73:106-110
41. Natsugoe S, Mueller J, Stein HJ et al. (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma 83:858-866
42. Niikura H, Okamura C, Utsonomiya H et al. (2004) Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92:669-674
43. Nijman HW, Khalifa M, Covens A (2004) What is the number of lymph nodes required for an "adequate" pelvic lymphadenectomy? Eur J Gynaecol Oncol 25:87-89
44. Palamba HW, Rombouts MC, Ruers TLM et al. (2001) Extranodal extension of axillary metastases of invasive breast carcionomas as a possible predictor for the total number of positive nodes. Eur J Surg Oncol 27:719-722
45. Panici PB, Angioli R (2002) Role of lymphadenectomy in ovarian cancer. Best Pract Res Clin Obstet Gynaecol 16:529-551
46. Plante M, Renaud MC, Tetu B et al. (2003) Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 91:494-503
47. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP (1999) Touch imprint cytologic analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 86:1346-1348
48. Rosen PP, Saigo PE, Braun DW et al. (1981) Axillary micro- and macrometastases in breast cancer. Ann Surg 194:585-591
49. Sakuragi N, Satoh C, Takeda N et al. (1999) Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547-1554
50. Schnürch HG (2000) Therapie des Vulva- und Vaginakarzinoms. Onkologe 6:1046-1060
51. Scholz HS, Lax SF, Benedicic C et al. (2003) Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB to IIB cervical cancer. Gynecol Oncol 90:605-609
52. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee (2002) Proceedings of the Consensus Conference on the role of sentinel node biopsy in carcinoma of the breast. April 19-22, 2001, Philadelphia, Pennsylvenia. Cancer 94:2542-2551
53. Silverberg SG, Connolly JL, Dabbs D et al. (2001) Recommendations for processing and reporting of lymph node specimens submitted for evaluating of metastatic disease. Am J Clin Pathol 115:799-801
54. Silverberg SG (2002) Sentinel node processing. Recommendations for pathologists. Am J Surg Pathol 26:383-385
55. Singletary SE, Greene FL, Sobin LH (2003) Classification of isolated tumor cells. Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 99:2740-2741
56. Terada KY, Shimizu DM, Wong JH (2000) Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44
57. Verheijen RHM, Pijpers R, van Diest PJ et al. (2000) Sentinel node detection in cervical cancer. Obstet Gynecol 96:135-138
58. Veronesi U, Paganelli G, Viale G et al. (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91:368-373
59. Weitz J, Kienle P, Magener A et al. (1999) Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5:1830-1836
60. Wittekind C, Meyer HJ, Bootz F (2002) TNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York Tokyo
61. Wittekind C, Greene FL, Henson DE et al. (2003) TNM-supplement. A commentary on uniform use. Wiley-Liss, New York
62. Yared MA, Middleton LP, Smith TL et al. (2002) Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 26:377-382